Loading asset research
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTXNasdaq · USD · StocksQuote as of · Exchange session not verified$12.50
-5.14%
Today
MLTX
Loading 1D prices…
Market cap
$1.1B
Volume
2.4M
52w high
$62.7552w low
$5.95Company profile
MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Zug, Switzerland, United States
Employees
130
Fiscal year end
1231
CIK
1821586
Session & valuation
Open$13.33
Previous close$13.18
Day high$13.55
Day low$12.47
30-day avg. volume1.3M
Outstanding shares85.1M
Diluted EPS-$3.53
Latest annual period
P/E (trailing)-3.54
P/E (forward)-3.76
Price / book2.44
Beta1.03
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| JANXJanux Therapeutics Inc. Common Stock | $1B | $10M | -1136.25% | -$1.83 | -3.39% | Buy |
| CRVSCorvus Pharmaceuticals Inc. Common Stock | $1.1B | $0.00 | — | -$0.53 | -0.23% | Buy |
| SVRASavara Inc. Common Stock | $1.1B | $0.00 | — | -$0.53 | -0.28% | Buy |
| APMDApnimed Inc. Common Stock | $1.1B | $38.5M | -2.42% | -$0.03 | -1.79% | Buy |
| OBXObsidian Therapeutics Inc. Common Stock | $1.1B | $0.00 | — | -$1.63 | +4.72% | Buy |